Patents by Inventor Jill Hamilton

Jill Hamilton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240065996
    Abstract: A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post-operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.
    Type: Application
    Filed: November 7, 2023
    Publication date: February 29, 2024
    Inventors: Jill Hamilton-Reeves, Jeffrey M. Holzbeierlein, Thomas Yankee
  • Patent number: 11857525
    Abstract: A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post-operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.
    Type: Grant
    Filed: February 15, 2016
    Date of Patent: January 2, 2024
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Jill Hamilton-Reeves, Jeffrey M. Holzbeierlein, Thomas Yankee
  • Publication number: 20180078107
    Abstract: A central vacuum system for collecting debris can include an autonomous vacuum system and a central vacuum fluidly connected to a remote intake port, the central vacuum being operable to generate a central airflow into the remote intake port. The autonomous vacuum system can comprise a collection bin fluidly connected to a debris intake and further include an onboard vacuum operable to generate a suction airflow from the debris intake into the collection bin to the onboard vacuum to draw debris through the debris intake into the collection bin. The autonomous vacuum system can further comprise an output connector fluidly connected to the collection bin. The output connector can be coupled to a remote intake port fluidly connected to a central vacuum operable to generate a central airflow to draw debris from the collection bin into the remote intake port positioned in the remote space.
    Type: Application
    Filed: September 22, 2017
    Publication date: March 22, 2018
    Inventors: Martin Gagnon, Mathieu Lalancette Jutras, Patrick Helbert, Richard R. Sinur, Brent Lillesand, Jessica Lindquist, Jill Hamilton, Jeremiah Bollengier, James Sheremeta
  • Publication number: 20180021279
    Abstract: A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post-operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.
    Type: Application
    Filed: February 15, 2016
    Publication date: January 25, 2018
    Inventors: Jill Hamilton-Reeves, Jeffrey M. Holzbeierlein, Thomas Yankee
  • Publication number: 20160155146
    Abstract: A system for facilitating the purchase and sale of advertising including a server with a non-transient computer readable storage medium. The server is in communication with at least one user device through a network, the user device being configured to receive user input. The server receives from the user device at least one Promotional Avail (PA) which includes a plurality of customizable elements of user input. The display of the user device presents a user interface, which is configured to present information related to the customizable elements in real time. The server is configured to cause to be presented proof-of-performance information to be presented on the user interface in response to a request.
    Type: Application
    Filed: December 1, 2015
    Publication date: June 2, 2016
    Applicant: Trade Marketing and Promotion Group Inc.
    Inventors: Michael J. Valentino, Richard Carthew, Jill Hamilton